Cite
HARVARD Citation
Rodziewicz, M. et al. (2023). Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study. Lancet. pp. e284-e292. [Online].